JAGUAR HEALTH, INC. Increase (Decrease) in Prepaid Expense
JAGUAR HEALTH, INC. (JAGX) reported Increase (Decrease) in Prepaid Expense of $57.81 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2017-08-09
- JAGUAR HEALTH, INC. increase (decrease) in prepaid expense for the quarter ending 2017-06-30 was -$27.41K, a 112.21% decline year-over-year.
- JAGUAR HEALTH, INC. increase (decrease) in prepaid expense for the quarter ending 2017-03-31 was $85.22K, a 71.75% decline year-over-year.
- JAGUAR HEALTH, INC. increase (decrease) in prepaid expense for the quarter ending 2016-12-31 was -$352.51K.
- JAGUAR HEALTH, INC. increase (decrease) in prepaid expense for the quarter ending 2016-09-30 was -$195.02K, a 195.21% decline year-over-year.
- JAGUAR HEALTH, INC. increase (decrease) in prepaid expense for fiscal 2016 was -$21.39K, a 107.13% decline from fiscal 2015.
- JAGUAR HEALTH, INC. increase (decrease) in prepaid expense for fiscal 2015 was $299.91K, a 1140.85% increase from fiscal 2014.
- JAGUAR HEALTH, INC. increase (decrease) in prepaid expense for fiscal 2014 was $24.17K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$27.41K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2017-08-09 | $57.81K 10-Q · filed 2017-08-09 | -$294.71K derived: sum of 3 quarters · filed 2017-08-09 | -$489.73K derived: sum of 4 quarters · filed 2017-08-09 |
| 2017-03-31 | $85.22K 10-Q/A · filed 2017-06-23 | -$267.30K derived: sum of 2 quarters · filed 2017-06-23 | -$462.32K derived: sum of 3 quarters · filed 2017-06-23 | -$237.83K derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-12-31 | -$352.51K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-15 | -$547.54K derived: sum of 2 quarters · filed 2017-02-15 | -$323.05K derived: sum of 3 quarters · filed 2017-08-09 | -$21.39K 10-K · filed 2017-02-15 |
| 2016-09-30 | -$195.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $29.46K derived: sum of 2 quarters · filed 2017-08-09 | $331.12K 10-Q · filed 2016-11-14 | $301.26K derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-06-30 | $224.49K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2017-08-09 | $526.15K 10-Q · filed 2017-08-09 | $496.29K derived: sum of 3 quarters · filed 2017-08-09 | $701.12K derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-03-31 | $301.66K 10-Q/A · filed 2017-06-23 | $271.80K derived: sum of 2 quarters · filed 2017-06-23 | $476.63K derived: sum of 3 quarters · filed 2017-06-23 | $503.43K derived: sum of 4 quarters · filed 2017-06-23 |
| 2015-12-31 | -$29.86K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-15 | $174.97K derived: sum of 2 quarters · filed 2017-02-15 | $201.77K derived: sum of 3 quarters · filed 2017-02-15 | $299.91K 10-K · filed 2017-02-15 |
| 2015-09-30 | $204.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $231.63K derived: sum of 2 quarters · filed 2016-11-14 | $329.77K 10-Q · filed 2016-11-14 | $287.20K derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $26.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $124.94K 10-Q · filed 2016-08-15 | $82.37K derived: sum of 3 quarters · filed 2016-08-15 | $116.12K derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-03-31 | $98.14K 10-Q · filed 2016-05-10 | $55.57K derived: sum of 2 quarters · filed 2016-05-10 | $89.32K derived: sum of 3 quarters · filed 2016-05-10 | $96.80K derived: sum of 4 quarters · filed 2016-05-10 |
| 2014-12-31 | -$42.57K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | -$8.83K derived: sum of 2 quarters · filed 2016-03-29 | -$1.34K derived: sum of 3 quarters · filed 2016-03-29 | $24.17K 10-K · filed 2016-03-29 |
| 2014-09-30 | $33.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $41.23K derived: sum of 2 quarters · filed 2015-11-13 | $66.74K 10-Q · filed 2015-11-13 | |
| 2014-06-30 | $7.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $33.00K 10-Q · filed 2015-08-13 | ||
| 2014-03-31 | $25.51K 10-Q · filed 2015-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |